$126.88
1.91% day before yesterday
NYSE, Apr 11, 10:10 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$126.88
-5.78 4.36% 1M
+10.76 9.27% 6M
+13.77 12.17% YTD
+15.43 13.84% 1Y
+6.84 5.70% 3Y
+41.03 47.79% 5Y
+80.35 172.68% 10Y
NYSE, Closing price Fri, Apr 11 2025
+2.38 1.91%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Market capitalization $220.05b
Enterprise Value $227.60b
P/E (TTM) P/E ratio 16.56
EV/FCF (TTM) EV/FCF 35.84
EV/Sales (TTM) EV/Sales 5.43
P/S ratio (TTM) P/S ratio 5.25
P/B ratio (TTM) P/B ratio 4.61
Dividend yield 1.77%
Last dividend (FY24) $2.24
Revenue growth (TTM) Revenue growth 4.59%
Revenue (TTM) Revenue $41.95b
EBIT (operating result TTM) EBIT $6.88b
Free Cash Flow (TTM) Free Cash Flow $6.35b
Cash position $7.97b
EPS (TTM) EPS $7.66
P/E forward 32.22
P/S forward 4.96
EV/Sales forward 5.13
Short interest 1.27%
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Abbott Laboratories forecast:

19x Buy
66%
9x Hold
31%
1x Sell
3%

Analyst Opinions

29 Analysts have issued a Abbott Laboratories forecast:

Buy
66%
Hold
31%
Sell
3%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
41,950 41,950
5% 5%
100%
- Direct Costs 20,599 20,599
3% 3%
49%
21,351 21,351
7% 7%
51%
- Selling and Administrative Expenses 8,433 8,433
11% 11%
20%
- Research and Development Expense 2,821 2,821
4% 4%
7%
10,097 10,097
4% 4%
24%
- Depreciation and Amortization 3,218 3,218
1% 1%
8%
EBIT (Operating Income) EBIT 6,879 6,879
7% 7%
16%
Net Profit 13,352 13,352
134% 134%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Positive
Kiplinger
5 days ago
Large-cap stocks are key additions to any well-rounded portfolio, but how do you find the best ones? We take a closer look here.
Positive
Seeking Alpha
12 days ago
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
Neutral
PRNewsWire
13 days ago
TRILUMINATE™ Pivotal data presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultaneously published in Circulation show the Abbott TriClip system reduces heart failure hospitalizations The latest results highlight significant improvements in tricuspid regurgitation and quality of life through two years ABBOTT PARK, Ill., March 31, 2025 /PRNewswire/ -- Abb...
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today